Stock DH DEFINITIVE HEALTHCARE CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Definitive Healthcare Corp.

Equities

DH

US24477E1038

Software

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
6.99 USD +3.86% Intraday chart for Definitive Healthcare Corp. -0.99% -29.68%
Apr. 16 Definitive Healthcare Introduces Carevoyance Sales Enablement Solution for Medtech Industry CI
Mar. 22 Definitive Healthcare Collaborating With VML Health on Key Opinion Leader Management Tool for Clients MT

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 2,713 1,155 1,156 823.3 - -
Enterprise Value (EV) 1 2,596 1,087 1,105 721 665.4 654
P/E ratio -144 x -183 x -5.55 x -34.3 x -39.9 x -31.8 x
Yield - - - - - -
Capitalization / Revenue 16.3 x 5.19 x 4.6 x 3.09 x 2.87 x 2.62 x
EV / Revenue 15.6 x 4.88 x 4.39 x 2.71 x 2.32 x 2.08 x
EV / EBITDA 46.4 x 17.1 x 14.8 x 8.36 x 6.84 x 5.72 x
EV / FCF 140 x 39.9 x 28.9 x 10.8 x 7.69 x 6.17 x
FCF Yield 0.71% 2.51% 3.46% 9.29% 13% 16.2%
Price to Book 4.77 x 1.8 x 1.3 x 1.14 x 1.13 x 1.12 x
Nbr of stocks (in thousands) 99,263 105,080 116,328 117,789 - -
Reference price 2 27.33 10.99 9.940 6.990 6.990 6.990
Announcement Date 2/23/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 166.2 222.7 251.4 266.3 287.4 314.7
EBITDA 1 - 55.99 63.75 74.45 86.28 97.25 114.3
EBIT 1 - 53.19 60.51 68.8 80.61 91.06 105.5
Operating Margin - 32.01% 27.18% 27.37% 30.27% 31.69% 33.54%
Earnings before Tax (EBT) 1 - -60.58 -39.44 -308.2 -23.92 -16.45 -
Net income 1 -51.16 -17.68 -6.037 -202.4 -21.99 -18.78 -14.48
Net margin - -10.64% -2.71% -80.5% -8.26% -6.53% -4.6%
EPS 2 -0.4000 -0.1900 -0.0600 -1.790 -0.2040 -0.1750 -0.2200
Free Cash Flow 1 - 18.48 27.25 38.21 66.97 86.49 106
FCF margin - 11.12% 12.24% 15.2% 25.15% 30.1% 33.69%
FCF Conversion (EBITDA) - 33.01% 42.75% 51.32% 77.62% 88.94% 92.73%
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - - - - -
Announcement Date 5/28/21 2/23/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 43.08 46.31 50.12 54.55 57.38 60.6 59.2 60.96 65.32 65.93 64.02 65.15 67.89 69.24 68.5
EBITDA 1 14.42 13.1 14.04 16.27 16.39 17.05 15.67 17.24 21.74 19.8 19.91 20.97 22.43 23.04 22.09
EBIT 1 13.71 12.27 13.24 15.26 15.67 16.33 14.09 16.02 20.38 18.31 18.51 19.37 21.17 21.67 20.83
Operating Margin 31.81% 26.49% 26.42% 27.98% 27.31% 26.95% 23.8% 26.28% 31.2% 27.77% 28.91% 29.73% 31.18% 31.29% 30.41%
Earnings before Tax (EBT) 1 -20.97 -14.09 -12.97 -9.792 -6.369 -10.31 -16.31 -13.09 -266.2 -12.19 -7.716 -6.291 -5.33 -4.584 -3.4
Net income 1 -7.978 -9.699 -8.624 -5.15 -2.689 10.43 -11.82 -8.566 -171.5 -10.23 -7.036 -5.477 -4.46 -3.664 -3.6
Net margin -18.52% -20.94% -17.21% -9.44% -4.69% 17.2% -19.96% -14.05% -262.57% -15.52% -10.99% -8.41% -6.57% -5.29% -5.26%
EPS 2 -0.0900 -0.1000 -0.0900 -0.0500 -0.0300 0.0700 -0.1100 -0.0800 -1.500 -0.0900 -0.0640 -0.0540 -0.0440 -0.0400 -0.0300
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/8/21 2/23/22 5/5/22 8/4/22 11/3/22 2/23/23 5/4/23 8/14/23 11/2/23 2/28/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 117 67.5 51.8 102 158 169
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - 18.5 27.3 38.2 67 86.5 106
ROE (net income / shareholders' equity) - 1.29% 3.94% 5.16% 6.03% 7.44% 8.68%
ROA (Net income/ Total Assets) - -0.92% -0.28% -10.3% 0.03% 0.27% 0.52%
Assets 1 - 1,921 2,119 1,974 -77,643 -7,025 -2,781
Book Value Per Share 2 - 5.730 6.120 7.640 6.130 6.160 6.230
Cash Flow per Share 2 - 0.2700 0.3500 0.3700 0.5900 0.3600 0.5400
Capex 1 - 6.73 8.33 2.98 5.56 5.89 5.59
Capex / Sales - 4.05% 3.74% 1.18% 2.09% 2.05% 1.78%
Announcement Date 5/28/21 2/23/22 2/23/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Definitive Healthcare Corp.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
6.99 USD
Average target price
10.4 USD
Spread / Average Target
+48.78%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

1st Jan change Capi.
DEFINITIVE HEALTHCARE CORP. Stock Definitive Healthcare Corp.
-29.68% 823M
MICROSOFT CORPORATION Stock Microsoft Corporation
+8.05% 3,020B
SYNOPSYS INC. Stock Synopsys Inc.
+5.58% 82.93B
CADENCE DESIGN SYSTEMS, INC. Stock Cadence Design Systems, Inc.
+3.69% 76.85B
DASSAULT SYSTÈMES SE Stock Dassault Systèmes SE
-14.62% 53.04B
PALANTIR TECHNOLOGIES INC. Stock Palantir Technologies Inc.
+31.16% 50.15B
ATLASSIAN CORPORATION Stock Atlassian Corporation
-24.56% 46.55B
THE TRADE DESK, INC. Stock The Trade Desk, Inc.
+17.75% 41.41B
SEA LIMITED Stock Sea Limited
+55.21% 35.63B
TAKE-TWO INTERACTIVE SOFTWARE, INC. Stock Take-Two Interactive Software, Inc.
-10.24% 24.64B
Other Software
  1. Stock Market
  2. Equities
  3. DH Stock
  4. Financials Definitive Healthcare Corp.